NT growth factor receptor market is anticipated to grow at a significant CAGR during the forecast period. Neurotrophic factor receptors or neurotrophin receptors are a group of growth factor receptors specifically binding to neurotrophins (neurotrophic factors). The major factor acceleraring the growth of the market is the increasing prevalence of cancer across the globe. According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. In men, prostate, lung, and colorectal cancers will account for an estimated 43% of all cancers diagnosed while for women, the three most common cancers are breast, lung, and colorectal which will account for an estimated 50% of all new cancer diagnoses in women in 2020. Furthermore, there were 18.1 million new cases and 9.5 million cancer-related mortalities globally in 2018 which is anticipated to rise to 29.5 million and the number of cancer-related mortalities to 16.4 million by 2040. Hence, the rising prevalence of the disease is driving the growth of the market.
Some major players in the market include Array BioPharma Inc., AstraZeneca Plc, and Daiichi Sankyo Company Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2020, AstraZeneca Plc announced the approval of Tagrisso (osimertinib) by the FDA in US. It is used for the treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumour resection.
To Request a Sample of our Report on NT Growth Factor Receptor Market: https://www.omrglobal.com/request-sample/nt-growth-factor-receptor-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Array BioPharma Inc., AstraZeneca Plc, and Daiichi Sankyo Company Ltd., among others.
NT Growth Factor Receptor Market Report by Segment
By Type
- AZD-7451
- Larotrectinib
- DS-6051
- LM-22B10
- Others
By Application
- Breast Cancer
- Brain Cancer
- Solid Tumor
- Colon Cancer
- Fibrosarcoma
- Others
A full Report of NT Growth Factor Receptor Market is Available @ https://www.omrglobal.com/industry-reports/nt-growth-factor-receptor-market
NT Growth Factor Receptor Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
